Distance Energy Healing – Traditional, Authentic, and Compassionate Support, including Prayer.
➤ guerisseurhealer.com Ads
You are currently viewing AstraZeneca Joins Pharma Investment Push in U.S. Amid Tariff Threat

The British drug maker plans to invest $50 billion in the United States as it seeks to appease President Trump.

The British-Swedish drugmaker AstraZeneca has promised to invest $50 billion in the United States by 2030, the latest in a string of pledges by pharmaceutical companies as they try to fend off President Trump’s threat to impose a 200 percent tariff on imported drugs.

Pascal Soriot, the chief executive of AstraZeneca, announced the plans on Monday in Washington while seated next to Kevin Hassett, the director of the U.S. National Economic Council, and Glenn Youngkin, the governor of Virginia, where the company will direct a major plank of the investment.

The plans “underpins our belief in America’s innovation in biopharmaceuticals and our commitment to the millions of patients who need our medicines in America and globally,” Mr. Soriot said.

The investment will go to projects like building a manufacturing plant in Virginia to make

Leave a Reply